A research team at Osaka University’s Institute of Laser Engineering has created a blue laser diode gun that could target and lock on to insects’ weak spots before firing a precision beam.
Led by Professors Hiroshi Fuji and Kazuhisa Yamamoto, the team first determined the spots of the insects such as the moth, desert locusts, and tobacco cutworm is most vulnerable to a laser blast.
This laser gun could become a game-changer as the tobacco cutworm is notoriously resistant to pesticides.
Using this technology, the concern of insects becoming resistant to pesticides would no longer exist, and the damage such chemicals cause to other wildlife and the environment would also be eliminated.
Also, with the efficient termination of pests near agricultural areas worldwide, an estimated US$200 billion in agricultural products could be saved, preventing food shortages.


Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Gold Drops Below $4,000 as Strong US Dollar and Fed Rate Hike Expectations Pressure Bullion
Australia Jobs Growth Strengthens Rate Hike Outlook
Republican Lawmaker Introduces AI Incident Reporting Bill to Strengthen U.S. AI Safety
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
Alphabet Replaces Verizon in Dow Jones Industrial Average
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
Oil Prices Drop as Middle East Supply Recovery Eases Market Concerns
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



